209 related articles for article (PubMed ID: 25940725)
21. Differences in non-Hodgkin lymphoma survival between young adults and children.
Tai E; Pollack LA; Townsend J; Li J; Steele CB; Richardson LC
Arch Pediatr Adolesc Med; 2010 Mar; 164(3):218-24. PubMed ID: 20194253
[TBL] [Abstract][Full Text] [Related]
22. Adolescent and young adult non-Hodgkin lymphoma.
Hochberg J; El-Mallawany NK; Abla O
Br J Haematol; 2016 May; 173(4):637-50. PubMed ID: 27071675
[TBL] [Abstract][Full Text] [Related]
23. Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries.
Avivi I; Farbstein D; Brenner B; Horowitz NA
Blood Rev; 2014 Sep; 28(5):213-20. PubMed ID: 25108745
[TBL] [Abstract][Full Text] [Related]
24. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
25. Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.
Burkhardt B; Oschlies I; Klapper W; Zimmermann M; Woessmann W; Meinhardt A; Landmann E; Attarbaschi A; Niggli F; Schrappe M; Reiter A
Leukemia; 2011 Jan; 25(1):153-60. PubMed ID: 21030984
[TBL] [Abstract][Full Text] [Related]
26. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.
Miles RR; Shah RK; Frazer JK
Br J Haematol; 2016 May; 173(4):582-96. PubMed ID: 26969846
[TBL] [Abstract][Full Text] [Related]
28. Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizons.
Galardy PJ; Bedekovics T; Hermiston ML
Br J Haematol; 2016 May; 173(4):625-36. PubMed ID: 27019108
[TBL] [Abstract][Full Text] [Related]
29. [Lymphomas in adolescents: are childhood lymphoma therapy protocols suitable for this patient group?].
Bence Z; Kovács G; Jakab Z; Csóka M; Müller J
Magy Onkol; 2008 Dec; 52(4):357-62. PubMed ID: 19068463
[TBL] [Abstract][Full Text] [Related]
30. Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.
Ganzel C; Pogrebijsky G; Krichevsky S; Neuman T; Yehuda DB
Exp Hematol; 2012 Sep; 40(9):698-704.e2. PubMed ID: 22659385
[TBL] [Abstract][Full Text] [Related]
31. Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report.
Lones MA; Perkins SL; Sposto R; Tedeschi N; Kadin ME; Kjeldsberg CR; Wilson JF; Zwick DL; Cairo MS
J Clin Oncol; 2002 May; 20(9):2293-301. PubMed ID: 11981000
[TBL] [Abstract][Full Text] [Related]
32. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
Tawfeek GA; Alhassanin S
Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
[TBL] [Abstract][Full Text] [Related]
33. Fine-needle aspiration cytology and flow cytometric immunophenotyping in diagnosis and classification of non-Hodgkin lymphoma in comparison to histopathology.
Ensani F; Mehravaran S; Irvanlou G; Aghaipoor M; Vaeli S; Hajati E; Khorgami Z; Nasiri S
Diagn Cytopathol; 2012 Apr; 40(4):305-10. PubMed ID: 22431318
[TBL] [Abstract][Full Text] [Related]
34. Diffuse aggressive histologies of non-hodgkin lymphoma: treatment and biology of limited disease.
Miller TP; Spier CM; Rimsza L
Semin Hematol; 2006 Oct; 43(4):207-12. PubMed ID: 17027654
[TBL] [Abstract][Full Text] [Related]
35. Pediatric non-Hodgkin lymphoma: a retrospective 14-year experience with Berlin-Frankfurt-Münster (BFM) protocols from a tertiary care hospital in Serbia.
Dokmanovic L; Krstovski N; Vukanic D; Brasanac D; Rodic P; Cvetkovic M; Janic D
Pediatr Hematol Oncol; 2012 Mar; 29(2):109-18. PubMed ID: 22376014
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of childhood non-hodgkin lymphoma.
Reiter A
Hematology Am Soc Hematol Educ Program; 2007; ():285-96. PubMed ID: 18024642
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC).
Fallanca F; Alongi P; Incerti E; Gianolli L; Picchio M; Kayani I; Bomanji J
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1837-48. PubMed ID: 27154522
[TBL] [Abstract][Full Text] [Related]
38. Minimal residual disease in non-Hodgkin lymphoma - current applications and future directions.
Chase ML; Armand P
Br J Haematol; 2018 Jan; 180(2):177-188. PubMed ID: 29076131
[TBL] [Abstract][Full Text] [Related]
39. Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.
Worch J; Rohde M; Burkhardt B
Pediatr Hematol Oncol; 2013 Sep; 30(6):465-83. PubMed ID: 23570584
[TBL] [Abstract][Full Text] [Related]
40. [Hungarian experience with non-Hodgkin's lymphoma in childhood].
Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
Magy Onkol; 2006; 50(3):253-9. PubMed ID: 17099787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
